Cross-Seal (Large Bore Closure) IDE Trial: Prospective, Multi-Center, Single Arm Study of the Cross-Seal Suture-Mediated Vascular Closure Device System
Cross-Seal Investigational Device Trial in Subjects Scheduled for an Interventional Vascular Procedure
Sponsor: Terumo Medical Corporation
Enrolling: Male and Female Patients
Study Length: 60 Days
Clinic Visits: 5
IRB Number: AAAS4111
U.S. Govt. ID: NCT03756558
Contact: Claudia Musat, Research Manager: (212) 342-4102 / cm2065@cumc.columbia.edu
Additional Study Information: Are you scheduled for an interventional vascular procedure, such as a Trans-catheter Aortic Valve Replacement (TAVR), Endovascular Aneurysm Repair (EVAR), Thoracic Endovascular Aortic Repair (TEVAR), or Balloon Aortic Valvuloplasty (BAV)? If yes, you may be eligible for this trial. This research trial studies the safety and efficacy of an Investigational Device (IDE) called the Cross-Seal Suture-Mediated Vascular Closure Device System. This device has not yet been approved by the FDA for use on the market.The device delivers percutaneous sutures (administers stitches through the skin) for the closure of large holes created in the common femoral artery access site during your endovascular procedure. The objective of the device is to safely and effectively help achieve hemostasis (the stopping of bleeding) of the artery in your thigh that was punctured for your surgery.
This study is closed
Investigator
Virendra Patel, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Are you scheduled for an elective or planned (e.g. not emergency) procedure involving access through the femoral artery? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Claudia Musat, Research Manager
cm2065@cumc.columbia.edu
(212) 342-4102